Richard Christopher
2017 - ICAD
In 2017, Richard Christopher earned a total compensation of $544.9K as Chief Financial Officer at ICAD, a 172% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $48,250 |
|---|---|
| Salary | $285,000 |
| Stock Awards | $179,666 |
| Other | $31,977 |
| Total | $544,893 |
Christopher received $285K in salary, accounting for 52% of the total pay in 2017.
Christopher also received $48.3K in non-equity incentive plan, $179.7K in stock awards and $32K in other compensation.
Rankings
In 2017, Richard Christopher's compensation ranked 11,544th out of 14,666 executives tracked by ExecPay. In other words, Christopher earned more than 21.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,544 out of 14,666 | 21st |
Division Manufacturing | 4,524 out of 5,768 | 22nd |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 620 out of 856 | 28th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 366 out of 528 | 31st |
Industry Surgical and Medical Instruments and Apparatus | 234 out of 333 | 30th |
Source: SEC filing on November 20, 2018.
Christopher's colleagues
We found two more compensation records of executives who worked with Richard Christopher at ICAD in 2017.
News
InVivo Therapeutics Holdings CEO Richard Toselli's 2022 pay slips 11% to $960K
December 5, 2023
InVivo Therapeutics Holdings CEO Richard Toselli's 2021 pay jumps 30% to $1.1M
August 18, 2022
InVivo Therapeutics Holdings CEO Richard Toselli's 2020 pay falls 34% to $832K
May 18, 2021
InVivo Therapeutics Holdings CEO Richard Toselli's 2019 pay jumps 69% to $1.3M
June 22, 2020